Scientific Session
Periodic fever syndromes, autoinflammatory diseases, Still’s disease and MAS/HLH
Philip Seo, MD, MHS
Johns Hopkins University
Baltimore, MD, United States
Disclosure(s): Amgen: Advisor or Review Panel Member (Ongoing); Janssen: Advisor or Review Panel Member (Terminated, October 3, 2022)
Robert Spiera, MD
Hosptial for Special Surgery
New York, NY, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); chemocentryx: Grant/Research Support (Ongoing); corbus: Grant/Research Support (Ongoing); Formation Biologics: Grant/Research Support (Ongoing); GSK: Consultant (Ongoing), Grant/Research Support (Ongoing); Inflarx: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Principia: Grant/Research Support (Ongoing); Sanofi: Consultant (Ongoing)